|Articles|September 16, 2015

Jacquelyn Powers on Empowering Patients With Information Regarding Genetic Testing

Jacquelyn Powers, genetic counselor, Abramson Cancer Center, University of Pennsylvania, discusses how to empower patients with information regarding genetic testing.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

Asian women who do not smoke in Northern California face rising lung cancer rates which are often diagnosed late due to current screening gaps.

Rising Lung Cancer Rates Targets Asian Women Nonsmokers in California

ByDr. Jeffrey B. Velotta

December 13th 2025

Emmy-winning journalist and author Suleika Jaouad recently delivered the keynote address at the inaugural Blood Cancer Heroes celebration.

Suleika Jaouad, Reporting From the Front Lines of Leukemia

BySuleika Jaouad

December 12th 2025

CURE spoke with Dr. Dickran Kazandjian about why MRD matters for patients with multiple myeloma.

What Does Minimal Residual Disease Mean?

ByDr. Dickran Kazandjian

December 11th 2025

The Emmy-winning journalist and author delivered the keynote address at the inaugural Blood Cancer Heroes event.

Suleika Jaouad Celebrates Blood Cancer Heroes With CURE and Blood Cancer United

BySuleika Jaouad

December 10th 2025

In a recent interview with CURE, Dr. Kai Tsao discussed treatment advancements for patients with prostate cancer.

Breaking Down the Prostate Cancer Treatment Renaissance

ByDr. Kai Tsao

December 9th 2025

Jacquelyn Powers on Empowering Patients With Information Regarding Genetic Testing

Newsletter

Related Content

Rising Lung Cancer Rates Targets Asian Women Nonsmokers in California

Suleika Jaouad, Reporting From the Front Lines of Leukemia

What Does Minimal Residual Disease Mean?

Suleika Jaouad Celebrates Blood Cancer Heroes With CURE and Blood Cancer United

Breaking Down the Prostate Cancer Treatment Renaissance

Trending on CURE

Acupuncture Improves Cognitive Function in Breast Cancer Survivors

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

FDA Grants Priority Review for Opdivo Combo in Advanced Lymphoma

Suleika Jaouad, Reporting From the Front Lines of Leukemia

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer